nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—Anaemia megaloblastic—Methotrexate—colon cancer	0.077	0.077	CcSEcCtD
Pentobarbital—Respiratory failure—Vincristine—colon cancer	0.0381	0.0381	CcSEcCtD
Pentobarbital—Hypoxia—Methotrexate—colon cancer	0.0286	0.0286	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Irinotecan—colon cancer	0.028	0.028	CcSEcCtD
Pentobarbital—Ataxia—Vincristine—colon cancer	0.0255	0.0255	CcSEcCtD
Pentobarbital—Injection site reaction—Capecitabine—colon cancer	0.0242	0.0242	CcSEcCtD
Pentobarbital—Ataxia—Fluorouracil—colon cancer	0.0238	0.0238	CcSEcCtD
Pentobarbital—Depressed level of consciousness—Capecitabine—colon cancer	0.0235	0.0235	CcSEcCtD
Pentobarbital—Apnoea—Methotrexate—colon cancer	0.0214	0.0214	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Capecitabine—colon cancer	0.0188	0.0188	CcSEcCtD
Pentobarbital—Hallucination—Vincristine—colon cancer	0.0187	0.0187	CcSEcCtD
Pentobarbital—Bradycardia—Irinotecan—colon cancer	0.0186	0.0186	CcSEcCtD
Pentobarbital—Respiratory failure—Methotrexate—colon cancer	0.0185	0.0185	CcSEcCtD
Pentobarbital—Depressed level of consciousness—Methotrexate—colon cancer	0.0175	0.0175	CcSEcCtD
Pentobarbital—Ataxia—Capecitabine—colon cancer	0.0166	0.0166	CcSEcCtD
Pentobarbital—Agitation—Vincristine—colon cancer	0.015	0.015	CcSEcCtD
Pentobarbital—Syncope—Irinotecan—colon cancer	0.0143	0.0143	CcSEcCtD
Pentobarbital—Loss of consciousness—Irinotecan—colon cancer	0.014	0.014	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Methotrexate—colon cancer	0.014	0.014	CcSEcCtD
Pentobarbital—Confusional state—Irinotecan—colon cancer	0.0131	0.0131	CcSEcCtD
Pentobarbital—Shock—Irinotecan—colon cancer	0.0128	0.0128	CcSEcCtD
Pentobarbital—Confusional state—Fluorouracil—colon cancer	0.0126	0.0126	CcSEcCtD
Pentobarbital—Hypotension—Vincristine—colon cancer	0.0125	0.0125	CcSEcCtD
Pentobarbital—Bradycardia—Capecitabine—colon cancer	0.0125	0.0125	CcSEcCtD
Pentobarbital—Ataxia—Methotrexate—colon cancer	0.0124	0.0124	CcSEcCtD
Pentobarbital—Hypotension—Irinotecan—colon cancer	0.0121	0.0121	CcSEcCtD
Pentobarbital—Hypotension—Fluorouracil—colon cancer	0.0116	0.0116	CcSEcCtD
Pentobarbital—Somnolence—Irinotecan—colon cancer	0.0116	0.0116	CcSEcCtD
Pentobarbital—Constipation—Vincristine—colon cancer	0.0114	0.0114	CcSEcCtD
Pentobarbital—Constipation—Irinotecan—colon cancer	0.0111	0.0111	CcSEcCtD
Pentobarbital—Somnolence—Fluorouracil—colon cancer	0.0111	0.0111	CcSEcCtD
Pentobarbital—Feeling abnormal—Irinotecan—colon cancer	0.0107	0.0107	CcSEcCtD
Pentobarbital—Body temperature increased—Vincristine—colon cancer	0.0106	0.0106	CcSEcCtD
Pentobarbital—Body temperature increased—Irinotecan—colon cancer	0.0103	0.0103	CcSEcCtD
Pentobarbital—Feeling abnormal—Fluorouracil—colon cancer	0.0103	0.0103	CcSEcCtD
Pentobarbital—Body temperature increased—Fluorouracil—colon cancer	0.00984	0.00984	CcSEcCtD
Pentobarbital—Hypersensitivity—Vincristine—colon cancer	0.00983	0.00983	CcSEcCtD
Pentobarbital—Hypersensitivity—Irinotecan—colon cancer	0.00958	0.00958	CcSEcCtD
Pentobarbital—Syncope—Capecitabine—colon cancer	0.00956	0.00956	CcSEcCtD
Pentobarbital—Loss of consciousness—Capecitabine—colon cancer	0.00937	0.00937	CcSEcCtD
Pentobarbital—Hypersensitivity—Fluorouracil—colon cancer	0.00917	0.00917	CcSEcCtD
Pentobarbital—Anxiety—Capecitabine—colon cancer	0.00904	0.00904	CcSEcCtD
Pentobarbital—Dizziness—Vincristine—colon cancer	0.00883	0.00883	CcSEcCtD
Pentobarbital—Confusional state—Capecitabine—colon cancer	0.00877	0.00877	CcSEcCtD
Pentobarbital—Dizziness—Irinotecan—colon cancer	0.00859	0.00859	CcSEcCtD
Pentobarbital—Shock—Capecitabine—colon cancer	0.00856	0.00856	CcSEcCtD
Pentobarbital—Vomiting—Vincristine—colon cancer	0.00849	0.00849	CcSEcCtD
Pentobarbital—Rash—Vincristine—colon cancer	0.00841	0.00841	CcSEcCtD
Pentobarbital—Dermatitis—Vincristine—colon cancer	0.00841	0.00841	CcSEcCtD
Pentobarbital—Headache—Vincristine—colon cancer	0.00836	0.00836	CcSEcCtD
Pentobarbital—Vomiting—Irinotecan—colon cancer	0.00826	0.00826	CcSEcCtD
Pentobarbital—Dizziness—Fluorouracil—colon cancer	0.00823	0.00823	CcSEcCtD
Pentobarbital—Rash—Irinotecan—colon cancer	0.0082	0.0082	CcSEcCtD
Pentobarbital—Dermatitis—Irinotecan—colon cancer	0.00819	0.00819	CcSEcCtD
Pentobarbital—Headache—Irinotecan—colon cancer	0.00814	0.00814	CcSEcCtD
Pentobarbital—Hypotension—Capecitabine—colon cancer	0.00813	0.00813	CcSEcCtD
Pentobarbital—Nausea—Vincristine—colon cancer	0.00793	0.00793	CcSEcCtD
Pentobarbital—Vomiting—Fluorouracil—colon cancer	0.00791	0.00791	CcSEcCtD
Pentobarbital—Rash—Fluorouracil—colon cancer	0.00785	0.00785	CcSEcCtD
Pentobarbital—Dermatitis—Fluorouracil—colon cancer	0.00784	0.00784	CcSEcCtD
Pentobarbital—Headache—Fluorouracil—colon cancer	0.0078	0.0078	CcSEcCtD
Pentobarbital—Nausea—Irinotecan—colon cancer	0.00772	0.00772	CcSEcCtD
Pentobarbital—Constipation—Capecitabine—colon cancer	0.00744	0.00744	CcSEcCtD
Pentobarbital—Nausea—Fluorouracil—colon cancer	0.00739	0.00739	CcSEcCtD
Pentobarbital—Feeling abnormal—Capecitabine—colon cancer	0.00717	0.00717	CcSEcCtD
Pentobarbital—Body temperature increased—Capecitabine—colon cancer	0.00688	0.00688	CcSEcCtD
Pentobarbital—Confusional state—Methotrexate—colon cancer	0.00653	0.00653	CcSEcCtD
Pentobarbital—Hypersensitivity—Capecitabine—colon cancer	0.00641	0.00641	CcSEcCtD
Pentobarbital—Hypotension—Methotrexate—colon cancer	0.00605	0.00605	CcSEcCtD
Pentobarbital—Somnolence—Methotrexate—colon cancer	0.00576	0.00576	CcSEcCtD
Pentobarbital—Dizziness—Capecitabine—colon cancer	0.00575	0.00575	CcSEcCtD
Pentobarbital—Vomiting—Capecitabine—colon cancer	0.00553	0.00553	CcSEcCtD
Pentobarbital—Rash—Capecitabine—colon cancer	0.00548	0.00548	CcSEcCtD
Pentobarbital—Dermatitis—Capecitabine—colon cancer	0.00548	0.00548	CcSEcCtD
Pentobarbital—Headache—Capecitabine—colon cancer	0.00545	0.00545	CcSEcCtD
Pentobarbital—Feeling abnormal—Methotrexate—colon cancer	0.00534	0.00534	CcSEcCtD
Pentobarbital—Nausea—Capecitabine—colon cancer	0.00517	0.00517	CcSEcCtD
Pentobarbital—Body temperature increased—Methotrexate—colon cancer	0.00512	0.00512	CcSEcCtD
Pentobarbital—Hypersensitivity—Methotrexate—colon cancer	0.00477	0.00477	CcSEcCtD
Pentobarbital—Dizziness—Methotrexate—colon cancer	0.00428	0.00428	CcSEcCtD
Pentobarbital—Vomiting—Methotrexate—colon cancer	0.00412	0.00412	CcSEcCtD
Pentobarbital—Rash—Methotrexate—colon cancer	0.00408	0.00408	CcSEcCtD
Pentobarbital—Dermatitis—Methotrexate—colon cancer	0.00408	0.00408	CcSEcCtD
Pentobarbital—Headache—Methotrexate—colon cancer	0.00406	0.00406	CcSEcCtD
Pentobarbital—Nausea—Methotrexate—colon cancer	0.00385	0.00385	CcSEcCtD
